Company Overview

COYA THERAPEUTICS, INC.

COYA
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
8M
2025 FY
Net Income
-21M
2025 FY
Shares Outstanding
17M
2025 FY
EPS
-1.27USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1835022
Exchange
Nasdaq
Location
US